SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-23-000113
Filing Date
2023-08-15
Accepted
2023-08-15 16:55:09
Documents
13
Period of Report
2023-08-15
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20230815x8k.htm   iXBRL 8-K 78579
2 EX-3.1 alim-20230815xex3_1.htm EX-3.1 14334
  Complete submission text file 0001267602-23-000113.txt   224311

Data Files

Seq Description Document Type Size
3 EX-101.SCH alim-20230815.xsd EX-101.SCH 2167
4 EX-101.LAB alim-20230815_lab.xml EX-101.LAB 19057
5 EX-101.PRE alim-20230815_pre.xml EX-101.PRE 12010
7 EXTRACTED XBRL INSTANCE DOCUMENT alim-20230815x8k_htm.xml XML 4999
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 231175570
SIC: 2834 Pharmaceutical Preparations